EichorEICHOR
Location: Hamden Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Hamden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Medical Research Center of Connecticut · Eli Lilly and Company · NCT07415044A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Medical Research Center of Connecticut · Janssen Research & Development, LLC · NCT07499232Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · CMR of Greater New Haven · Eli Lilly and Company · NCT05986292De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital-Hamden Care Center · NRG Oncology · NCT04852887A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2 · CMR of Greater New Haven · Eli Lilly and Company · NCT07285018A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · CMR of Greater New Haven, LLC · Eli Lilly and Company · NCT07282600Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Smilow Cancer Hospital-Hamden Care Center · ECOG-ACRIN Cancer Research Group · NCT04239573OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · ClinTrial Hamden · Amgen · NCT07136012VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · Medical Research Center of Connecticut · Vedanta Biosciences, Inc. · NCT06237452Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Rela
Phase 2 · Kailera Clinical Site · Kailera · NCT07497880Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-
Phase 3 · Smilow Cancer Hospital-Hamden Care Center · NRG Oncology · NCT07166406Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Phase 2 · Marea Site 306 · Marea Therapeutics · NCT07028749Fecal Microbiota Transplant National Registry
Phase N/A · Yale New Haven Hospital · American Gastroenterological Association · NCT03325855Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 3 · Smilow Cancer Hospital-Hamden Care Center · NRG Oncology · NCT06958328A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Phase 2 · CMR of Greater New Haven, LLC · Eli Lilly and Company · NCT07269210A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Medical Research Center of Connecticut, LLC · Eli Lilly and Company · NCT06598943Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small
Phase 2/Phase 3 · Smilow Cancer Hospital-Hamden Care Center · National Cancer Institute (NCI) · NCT04402788EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · CMR of Greater New Haven, LLC · Boehringer Ingelheim · NCT07064473A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · Medical Research Center of Connecticut, LLC · Takeda · NCT06045754A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Medical Research Center of Connecticut · Eli Lilly and Company · NCT07165028Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
Phase 1/Phase 2 · Smilow Cancer Hospital - Hamden Care Center · Yale University · NCT04210492A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart
Phase 3 · Chase Medical Research LLC · Novo Nordisk A/S · NCT07481630Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Phase 2 · Research Site · AstraZeneca · NCT07285213A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Di
Phase 3 · Medical Research Center of Connecticut ( Site 5005) · Merck Sharp & Dohme LLC · NCT06430801
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.